아토피피부염 환자에서 중증도 변화에 따른 SCORAD index와 혈청 총 IgE 및 호산구 수의 상관관계
The Correlation between SCORAD Index and Serum Total IgE or Eosinophil Count in Individual Patients of Atopic Dermatitis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives : This study was aimed to evaluate the correlation between changes in disease severity and serum total IgE or eosinophil count in individual patients of atopic dermatitis depending on the change of severity. Methods : We performed a retrospective chart review of 8 cases of atopic dermatitis who underwent blood tests more than five times. Disease severity was assessed by objective SCORing of Atopic Dermatitis index (OSI). Blood tests include serum total IgE, eosinophil counts, aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN) and serum creatinine (SCr). In each subject, on the day that the blood test was performed, OSI was also assesed by a same physician. Correlation between OSI and total IgE or eosinophil count was analysed by nonparametric correlation analysis. Results : There was a statistically significant positive correlation between OSI and total IgE in three cases and a positive correlation between OSI and eosinophil count in two cases. In other three cases, there were no significant correlation. There were no cases that OSI correlated with total IgE and eosinophil count at the same time. In all cases, AST, ALT, BUN and SCr were stable. Conclusions : We suggest that total IgE and eosinophil count may reflect the severity of atopic dermatitis differently in individual patients. We also suggest that total IgE and eosinophil counts may be used as biomarkers to predict the severity of atopic dermatitis in some patients depending on the underlying pathology.
Abstract
Objectives : This study was aimed to evaluate the correlation between changes in disease severity and serum total IgE or eosinophil count in individual patients of atopic dermatitis depending on the change of severity. Methods : We performed a retrospective chart review of 8 cases of atopic dermatitis who underwent blood tests more than five times. Disease severity was assessed by objective SCORing of Atopic Dermatitis index (OSI). Blood tests include serum total IgE, eosinophil counts, aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN) and serum creatinine (SCr). In each subject, on the day that the blood test was performed, OSI was also assesed by a same physician. Correlation between OSI and total IgE or eosinophil count was analysed by nonparametric correlation analysis. Results : There was a statistically significant positive correlation between OSI and total IgE in three cases and a positive correlation between OSI and eosinophil count in two cases. In other three cases, there were no significant correlation. There were no cases that OSI correlated with total IgE and eosinophil count at the same time. In all cases, AST, ALT, BUN and SCr were stable. Conclusions : We suggest that total IgE and eosinophil count may reflect the severity of atopic dermatitis differently in individual patients. We also suggest that total IgE and eosinophil counts may be used as biomarkers to predict the severity of atopic dermatitis in some patients depending on the underlying pathology.
참고문헌 (21)
- Williams H, "Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood", Journal of allergy and clinical immunology, 103(1), pp.125~138 (1999)[DOI]
- Weidinger S, "Atopic dermatitis", Lancet, 387(10023), pp.1109~1122 (2016)[DOI]
- Hanifin J, "Diagnostic features of atopic dermatitis", Acta Derm Venereol(Stockh)(suppl), 92, pp.44~47 (1980)
- 박근화, "SCORing atopic dermatitis index로 평가한 아토피피부염의 중증도와 혈액 검사와의 연관성", Allergy Asthma & Respiratory Disease, 1(1), pp.79~83 (2013), 대한 소아알레르기 호흡기학회
- Noh G, "Blood eosinophils and serum IgE as predictors for prognosis of interferongamma therapy in atopic dermatitis", Allergy, 53(12), pp.1202~1207 (1998)[DOI]
- 김명남, "아토피 피부염에서 말초 혈액내 호산구 수, 혈청 총 IgE, eosinophil cationic protein, IL-4 및 soluble E-selectin의 변화", 대한피부과학회지, 40(11), pp.1367~1373 (2002), 대한피부과학회
- Lee JH, "A Study on the Relationship of the Severity of Atopic Dermatitis, Serum IgE and IFN-gamma", Korean Journal of Dermatology, 39(10), pp.1067~1071 (2001)
- Kiehl P, "Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining", British Journal of Dermatology, 145(5), pp.720~729 (2001)[DOI]
- Simon D, "Eosinophils and atopic dermatitis", Allergy, 59(6), pp.561~570 (2004)[DOI]
- Kunz B, "Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis", Dermatology, 195(1), pp.10~19 (1997)
- Bieber T, "Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine", Allergy, 67(12), pp.1475~1482 (2012)
- Thijs JL, "Current and future biomarkers in atopic dermatitis", Immunology and Allergy Clinics, 37(1), pp.51~61 (2017)[DOI]
- Novak N, "Allergic and nonallergic forms of atopic diseases", Journal of Allergy and Clinical Immunology, 112(2), pp.252~262 (2003)[DOI]
- Clendenning WE, "Serum IgE studies in atopic dermatitis", Journal of Investigative Dermatology, 61(4), pp.233~236 (1973)[DOI]
- Kang DG, "The serum eosinophils and serum IgE in patients with atopic dermatitis", Korean Journal of Dermatology, 30(1), pp.51~56 (1992)
- Simon D, "Epidemiology clinical features and immunology of the intrinsic(nonIgEmediated) type of atopic dermatitis (constitutional dermatitis)", Allergy, 56(9), pp.841~849 (2001)[DOI]
- Uehara M, "Blood eosinophilia in atopic dermatitis", Clinical and experimental dermatology, 15(4), pp.264~266 (1990)[DOI]
- Park SY, "Utility of eosinophil cationic protein levels in the diagnosis of intrinsic atopic dermatitis", Acta dermato-venereologica, 94(3), pp.333~334 (2014)[DOI]
- Kim HS, "Eosinophil-derived neurotoxin as a biomarker for disease severity and relapse in recalcitrant atopic dermatitis", Annals of Allergy, Asthma & Immunology, 119(5), pp.441~445 (2017)[DOI]
- Thijs JL, "A panel of biomarkers for disease severity in atopic dermatitis", Clinical & Experimental Allergy, 45(3), pp.698~701 (2015)[DOI]
- Thijs JL, "Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis", Journal of Allergy and Clinical Immunology, 140(3), pp.730~737 (2017)[DOI]